GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Animalcare Group PLC (LSE:ANCR) » Definitions » Research & Development

Animalcare Group (LSE:ANCR) Research & Development : £3.10 Mil (TTM As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Animalcare Group Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Animalcare Group's Research & Development for the six months ended in Dec. 2023 was £1.70 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was £3.10 Mil.


Animalcare Group Research & Development Historical Data

The historical data trend for Animalcare Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Animalcare Group Research & Development Chart

Animalcare Group Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.09 3.49 3.13 3.03 3.10

Animalcare Group Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.92 1.73 1.30 1.40 1.70

Animalcare Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £3.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Animalcare Group  (LSE:ANCR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Animalcare Group Research & Development Related Terms

Thank you for viewing the detailed overview of Animalcare Group's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Animalcare Group (LSE:ANCR) Business Description

Traded in Other Exchanges
Address
Monks Cross Drive, Moorside, York, GBR, YO32 9LB
Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. Its only reportable segment is Pharmaceutical which includes the development and marketing of innovative pharmaceutical products. The company has a presence in Belgium, The Netherlands, Germany, Italy, Portugal, European Union - Other, Asia, Middle East Africa, Spain, the United Kingdom, and Other Countries of which Spain derives a majority of revenue to the company.

Animalcare Group (LSE:ANCR) Headlines

No Headlines